Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.

Van den Eynde F, Senturk V, Naudts K, Vogels C, Bernagie K, Thas O, van Heeringen C, Audenaert K.

J Clin Psychopharmacol. 2008 Apr;28(2):147-55. doi: 10.1097/JCP.0b013e318166c4bf.

PMID:
18344724
2.

Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.

Mercer D, Douglass AB, Links PS.

J Pers Disord. 2009 Apr;23(2):156-74. doi: 10.1521/pedi.2009.23.2.156. Review.

PMID:
19379093
3.

Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Bellino S, Paradiso E, Bogetto F.

CNS Drugs. 2008;22(8):671-92. Review.

PMID:
18601305
4.

Impulsivity as a common process across borderline personality and substance use disorders.

Bornovalova MA, Lejuez CW, Daughters SB, Zachary Rosenthal M, Lynch TR.

Clin Psychol Rev. 2005 Sep;25(6):790-812. Review.

PMID:
16005556
5.

Clinical use of quetiapine in disease states other than schizophrenia.

Adityanjee, Schulz SC.

J Clin Psychiatry. 2002;63 Suppl 13:32-8. Review.

6.

Aggression in borderline personality disorder.

Látalová K, Prasko J.

Psychiatr Q. 2010 Sep;81(3):239-51. doi: 10.1007/s11126-010-9133-3. Review.

PMID:
20390357
7.

The borderline diagnosis II: biology, genetics, and clinical course.

Skodol AE, Siever LJ, Livesley WJ, Gunderson JG, Pfohl B, Widiger TA.

Biol Psychiatry. 2002 Jun 15;51(12):951-63. Review.

PMID:
12062878
8.

[Symptom-focussed drug therapy in borderline personality disorder].

Schmahl C, Bohus M.

Fortschr Neurol Psychiatr. 2001 Jul;69(7):310-21. Review. German.

PMID:
11488246
9.

Impulsive aggression in borderline personality disorder.

Goodman M, New A.

Curr Psychiatry Rep. 2000 Feb;2(1):56-61. Review.

PMID:
11122933
10.

The relationship of borderline personality disorder to the affective disorders.

Kroll J, Ogata S.

Psychiatr Dev. 1987 Summer;5(2):105-28. Review.

PMID:
2888107
11.

[Borderline personality disorder and bipolar II disorder--similarities and differences].

Massler A, Zatsman G.

Harefuah. 2011 Apr;150(4):349-52, 419. Review. Hebrew.

PMID:
22164915
12.

Chronic pain and the measurement of personality: do states influence traits?

Fishbain DA, Cole B, Cutler RB, Lewis J, Rosomoff HL, Rosomoff RS.

Pain Med. 2006 Nov-Dec;7(6):509-29. Review.

PMID:
17112364
13.

Prospective studies of outcome. Understanding mechanisms of change in patients with borderline personality disorder.

Links PS, Heslegrave RJ.

Psychiatr Clin North Am. 2000 Mar;23(1):137-50. Review.

PMID:
10729936
14.

[Borderline personality disorder, self-mutilation and suicide: literature review].

Oumaya M, Friedman S, Pham A, Abou Abdallah T, Guelfi JD, Rouillon F.

Encephale. 2008 Oct;34(5):452-8. doi: 10.1016/j.encep.2007.10.007. Epub 2008 Feb 20. Review. French.

PMID:
19068333
15.

The development of impulsivity and suicidality in borderline personality disorder.

Paris J.

Dev Psychopathol. 2005 Fall;17(4):1091-104. Review.

PMID:
16613432
16.

Is there any drug treatment of choice for the borderline patient?

Soloff PH.

Acta Psychiatr Scand Suppl. 1994;379:50-5. Review.

PMID:
8010152
17.

Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.

Bellino S, Rinaldi C, Bozzatello P, Bogetto F.

Curr Med Chem. 2011;18(22):3322-9. Review.

PMID:
21728970
18.

Update on pharmacotherapy of borderline personality disorder.

Zanarini MC.

Curr Psychiatry Rep. 2004 Feb;6(1):66-70. Review.

PMID:
14738708
19.

Off-label prescription of quetiapine in psychiatric disorders.

Rowe DL.

Expert Rev Neurother. 2007 Jul;7(7):841-52. Review.

PMID:
17610391
20.

Psychopharmacology of borderline personality disorder.

Raj YP.

Curr Psychiatry Rep. 2004 Jun;6(3):225-31. Review.

PMID:
15142476

Supplemental Content

Support Center